Science Explorer Back to mapMap
Discussion
Company · Malvern · United States

Progenra (United States)

Research works
45
▲ 29% vs 2018-21
Citations
2.1k
45.5 per fractional work
Top-10% rate
8.3%
all institutions 10.0%
Open access
51%
world 40%
International
16%
world 18%

Not ranked overall: Progenra (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Progenra (United States) work in?

In all years, 69% of research at Progenra (United States) is in Life Sciences, 24% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (62%), Medicine (24%), Immunology and Microbiology (6%). It does 3.5× the world's share of Life Sciences.

Life Sciences: 31 fractional works · 68.9% of its workBiochemistry, Genetics and Molecular Biology: 28 fractional works · 62.0% of its workMolecular Biology: 25 fractional works · 55.6% of its workCancer Research: 1 fractional works · 3.2% of its workCell Biology: 1 fractional works · 1.5% of its workGenetics: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 5.7% of its workImmunology: 3 fractional works · 5.7% of its workNeuroscience: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workHealth Sciences: 11 fractional works · 23.7% of its workMedicine: 11 fractional works · 23.7% of its workOncology: 5 fractional works · 11.9% of its workEpidemiology: 1 fractional works · 2.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.9% of its workInfectious Diseases: 1 fractional works · 1.8% of its workFamily Practice: 1 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.2% of its workHematology: 0 fractional works · 0.9% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workRheumatology: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 5.3% of its workEngineering: 1 fractional works · 3.0% of its workCivil and Structural Engineering: 1 fractional works · 1.6% of its workBiomedical Engineering: 0 fractional works · 0.8% of its workMechanics of Materials: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.7% of its workPaleontology: 0 fractional works · 0.7% of its workEnvironmental Science: 0 fractional works · 0.7% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.7% of its workSpectroscopy: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 2.1% of its workArts and Humanities: 1 fractional works · 1.5% of its workArcheology: 0 fractional works · 0.7% of its workHistory: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workALL ITS WORKProgenra (UnitedStates)45fractional works, all years
Life Sciences69%Physical Sciences5%Health Sciences24%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2862.0%
    2. Immunology and Microbiology35.7%
    3. Neuroscience00.7%
    4. Pharmacology, Toxicology and Pharmaceutics00.4%
    5. Agricultural and Biological Sciences00.2%
    1. Medicine1123.7%
    1. Engineering13.0%
    2. Earth and Planetary Sciences00.7%
    3. Environmental Science00.7%
    4. Chemistry00.7%
    5. Computer Science00.1%
    1. Arts and Humanities11.5%
    2. Economics, Econometrics and Finance00.4%
    3. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.89× its world share, 2 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 8.40× its world share, 0 worksPharmacology, Toxico…Engineering: 0.24× its world share, 0 worksEngineeringMedicine: 2.96× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 1.38× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.18× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.4×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics8.40×0 works
  2. Biochemistry, Genetics and Molecular Biology5.89×2 works
  3. Medicine2.96×3 works
  4. Economics, Econometrics and Finance1.38×0 works
  5. Engineering0.24×0 works
  6. Social Sciences0.18×0 works

Who are the top researchers at Progenra (United States)?

Ranked on the quality score, Michael R. Mattern, Suresh Kumar and Benjamin Thomas Nicholson lead among researchers whose main affiliation is Progenra (United States).

  1. 1 Michael R. Mattern United States · #272,878 worldwide 8.6k citations · 126 works
  2. 2 Suresh Kumar United States · #293,432 worldwide 4.3k citations · 64 works
  3. 3 Benjamin Thomas Nicholson United States · #334,342 worldwide 5.5k citations · 105 works
  4. 4 Tauseef R. Butt United States · #380,657 worldwide 6.2k citations · 97 works
  5. 5 David E. Sterner United States · #389,757 worldwide 4.7k citations · 40 works
  6. 6 Seth J. Goldenberg United States · #671,206 worldwide 2.2k citations · 25 works
  7. 7 Matthew P. Kodrasov United States · #1,490,348 worldwide 1k citations · 16 works
  8. 8 Craig A. Leach United States · #1,711,582 worldwide 2k citations · 34 works
  9. 9 Jian Wu United States · #4,384,763 worldwide 2.6k citations · 177 works
All ranked researchers at Progenra (United States)

What are the most cited papers from Progenra (United States)?

The most cited paper from Progenra (United States) is "A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance" (Dharminder Chauhan et al., 2012), with 592 citations. Next come "Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO" (507) and "Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes" (416).

Most cited papers
#PaperReleasedCitations
1 A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance Dharminder Chauhan et al. · Cancer Cell Open access Sep 2012 592
2 Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO Jeffrey G. Marblestone, Suzanne C. Edavettal, Yiting Lim et al. · Protein Science Open access 2 Dec 2005 507
3 Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes Mikael Altun, Holger Kramer, Lianne I. Willems et al. · Chemistry & Biology Open access Nov 2011 416
4 The Multifaceted Roles of USP7: New Therapeutic Opportunities Benjamin Thomas Nicholson, Suresh Kumar · Cell Biochemistry and Biophysics 5 Apr 2011 241
5 Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47 Joseph A. Weinstock, Jian Wu, Ping Cao et al. · ACS Medicinal Chemistry Letters Open access 11 Sep 2012 187
All 71 most cited papers, with filters and sorting

Which keywords describe research at Progenra (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Proteasome Inhibitors, Proteasome, Ubiquitin, Tumor Microenvironment, Transcriptional Regulation, BET Bromodomains and PROTACs.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Cancer Therapy22▲ 77×7 topics
  2. Proteasome Inhibitors14▲ 441×2 topics
  3. Proteasome14▲ 755×1 topic
  4. Ubiquitin14▲ 755×1 topic
  5. Tumor Microenvironment5▲ 33×4 topics
  6. Transcriptional Regulation4▲ 38×2 topics
  7. BET Bromodomains4▲ 447×1 topic
  8. Cancer4▲ 6.5×10 topics
  9. PROTACs4▲ 447×1 topic
  10. Gene Expression4▲ 13×3 topics
  11. Apoptosis4▲ 20×5 topics
  12. PET Imaging3▲ 31×2 topics
  13. Fibroblast Activation Protein3▲ 129×1 topic
  14. Immunosuppression3▲ 57×1 topic
  15. Epigenetic Regulation3▲ 29×2 topics
  16. HDAC Inhibitors3▲ 296×1 topic
  17. Histone Deacetylases3▲ 296×1 topic
  18. Mutation2▲ 35×2 topics
  19. Cell Cycle2▲ 79×1 topic
  20. Regulation2▲ 7.7×2 topics
  21. p532▲ 105×1 topic
  22. Immunity2▲ 13×5 topics
  23. Immune System2▲ 11×3 topics
  24. Cell Death2▲ 16×4 topics
  25. Inflammation2▲ 1.37×4 topics
  26. Oxidative Stress1▲ 1.62×4 topics
  27. Glycosylation1▲ 12×2 topics
  28. HIF-11▲ 32×1 topic
  29. Warburg Effect1▲ 32×1 topic
  30. Glycans1▲ 28×1 topic
  31. Mucins1▲ 28×1 topic
  32. Parkinson's Disease1▲ 9.7×2 topics

Which research topics does Progenra (United States) publish most on?

By volume in 2022-now: Ubiquitin and proteasome pathways, Medication Adherence and Compliance, Autophagy in Disease and Therapy and SARS-CoV-2 and COVID-19 Research.

  1. 1 Ubiquitin and proteasome pathways Molecular Biology 1 works
  2. 2 Medication Adherence and Compliance Family Practice 1 works
  3. 3 Autophagy in Disease and Therapy Epidemiology 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 Microtubule and mitosis dynamics Cell Biology 0 works
  6. 6 Influenza Virus Research Studies Epidemiology 0 works
  7. 7 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  8. 8 Cancer-related Molecular Pathways Oncology 0 works
  9. 9 Pharmaceutical industry and healthcare Pharmacology 0 works
  10. 10 Protein Degradation and Inhibitors Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.4%not open48.6%

World: 40% of research is openly available.

with international co-authors15.8%domestic only84.2%

World: 18% is written across borders.

How has Progenra (United States)'s research output changed?

Output in 2022-2025 was 29% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Progenra (United States) as a percentage of every work published that year, 0.0000098% in 2024.

still counting0.000050%0.00010%0.00015%Progenra (United States)0.0000085% in 202520102020

Fractional works of Progenra (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Malvern

All research institutions in Malvern

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Progenra (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.